For the launching event of Blincyto® (blinatumomab) in Chile, the meeting "Update on the management of ALL" was held on March 17, 2022 at the Ritz Carlton hotel in the city of Santiago de Chile. We had the opportunity to have Drs. Maria Marta Rivas (Argentina) and María Angélica Wiestruck (Chile), international speakers and leaders in the field, who presented and debated with the public about the treatment of ALL and everything related to the administration and experience with blinatumomab. We also had the honor of introducing Dr. Nicola Gökbuget who gave a virtual presentation from Frankfurt, Germany.
The hybrid model of our events, established since the travel restrictions resulting from the pandemic, enables us to reach the entire medical and scientific community and be able to interact live with those who were unable to participate in person. We thank each of you for your time and active participation.
It is very gratifying for Varifarma Chile to be able to offer an innovative therapy to patients with acute lymphoblastic leukemia with the backing of science regarding the safety and efficacy of the product. Blincyto® is now also available in Ecuador and Peru.